Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism

Exclusion Criteria

• •1. A clear history of chronic liver disease, or abnormal liver function (ALT/AST\>1.5×ULN).
• •2. There is evidence of active inflammatory myopathy or CK\>3×ULN.
• •3. Being allergic to statins or severe side effects were caused by taking statins(including myolysis).
• •4. Combined with hypothyroidism, nephrotic syndrome, alcoholism, pancreatitis, lupus erythematosus.
• •5. All patients who had a clear adverse reaction to the statins.
• •6. Possibility of pregnancy, pregnant or lactating patients.
• •7. There may be limited medical history of subjects who may can not complete their treatment during the study period.
• •8. Undergoing or planning to functional renal transplantation.
• •9. The life expectancy is no more than half a year.
• •10. Patients who are taking birth control pills, steroid hormones and imidazole drugs.
• •11. Patients who have participated in clinical trials of other drugs within 1 month, or known that clinical follow-up or research on drug compliance poorly.
• •12. Patients are not fit to be tested according to the researchers.